56 research outputs found
Lipid profiling of brain tissue and blood after traumatic brain injury: A review of human and experimental studies.
Traumatic brain injury (TBI) is a neurological condition which affects a large number of individuals worldwide, across all ages. It can lead to major physical, cognitive and psychological impairment, and represents a considerable health cost burden. TBI is a heterogeneous condition and there has been intense effort over the last decade to identify better biomarkers, which would enable an optimum and personalized treatment. The brain is highly enriched in a variety of lipids, including fatty acids, glycerophospholipids, glycerolipids, sterols and sphingolipids. There is accumulating evidence in clinical studies in TBI patients and also in experimental models of TBI, that injury triggers a complex pattern of changes in various lipid classes. Such changes can be detected in blood (plasma/serum), cerebrospinal fluid and also in brain tissue. They provide new insights into the pathophysiology of TBI, and have biomarker potential. Here, we review the various changes reported and discuss the scope and value of these lipid focused studies within the TBI field
a global network of chronic kidney disease cohorts
Background Chronic kidney disease (CKD) is a global health burden, yet it is
still underrepresented within public health agendas in many countries. Studies
focusing on the natural history of CKD are challenging to design and conduct,
because of the long time-course of disease progression, a wide variation in
etiologies, and a large amount of clinical variability among individuals with
CKD. With the difference in health-related behaviors, healthcare delivery,
genetics, and environmental exposures, this variability is greater across
countries than within one locale and may not be captured effectively in a
single study. Methods Studies were invited to join the network. Prerequisites
for membership included: 1) observational designs with a priori hypotheses and
defined study objectives, patient-level information, prospective data
acquisition and collection of bio-samples, all focused on predialysis CKD
patients; 2) target sample sizes of 1,000 patients for adult cohorts and 300
for pediatric cohorts; and 3) minimum follow-up of three years. Participating
studies were surveyed regarding design, data, and biosample resources. Results
Twelve prospective cohort studies and two registries covering 21 countries
were included. Participants age ranges from >2 to >70 years at inclusion, CKD
severity ranges from stage 2 to stage 5. Patient data and biosamples (not
available in the registry studies) are measured yearly or biennially. Many
studies included multiple ethnicities; cohort size ranges from 400 to more
than 13,000 participants. Studies’ areas of emphasis all include but are not
limited to renal outcomes, such as progression to ESRD and death. Conclusions
iNET-CKD (International Network of CKD cohort studies) was established, to
promote collaborative research, foster exchange of expertise, and create
opportunities for research training. Participating studies have many
commonalities that will facilitate comparative research; however, we also
observed substantial differences. The diversity we observed across studies
within this network will be able to be leveraged to identify genetic,
behavioral, and health services factors associated with the course of CKD.
With an emerging infrastructure to facilitate interactions among the
investigators of iNET-CKD and a broadly defined research agenda, we are
confident that there will be great opportunity for productive collaborative
investigations involving cohorts of individuals with CKD
Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/139089/1/jah31554.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139089/2/jah31554_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139089/3/jah31554-sup-0001-TableS1.pd
Recommended from our members
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation : Data From ROCKET AF
M. Kaste on työryhmän ROCKET AF Steering Comm jäsen.Background-Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. Methods and Results-In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) study, patients with nonvalvular atrial fibrillation were randomized to rivaroxaban or dose-adjusted warfarin. Cox proportional hazards regression with backward elimination identified factors at randomization that were independently associated with all-cause mortality in the 14 171 participants in the intention-to-treat population. The median age was 73 years, and the mean CHADS(2) score was 3.5. Over 1.9 years of median follow-up, 1214 (8.6%) patients died. Kaplan-Meier mortality rates were 4.2% at 1 year and 8.9% at 2 years. The majority of classified deaths (1081) were cardiovascular (72%), whereas only 6% were nonhemorrhagic stroke or systemic embolism. No significant difference in all-cause mortality was observed between the rivaroxaban and warfarin arms (P=0.15). Heart failure (hazard ratio 1.51, 95% CI 1.33-1.70, P= 75 years (hazard ratio 1.69, 95% CI 1.51-1.90, P Conclusions-In a large population of patients anticoagulated for nonvalvular atrial fibrillation, approximate to 7 in 10 deaths were cardiovascular, whereasPeer reviewe
Gd–LIII EXAFS study of structural and dynamic properties of between 10 and 300 K
The location of endohedral Gd ions in Gd@C82 is studied by Gd–LIII X-ray absorption spectroscopy in the temperature range 10–300 K. The near-edge data point to a covalent bond of trivalent Gd ions with the carbon cage. The EXAFS data can be well fitted with a Gd position above a carbon hexagon with two neighbour shells of carbon at distances R1,2=2.49(3) and 2.95(5) Å, corresponding to a large off-center position of about 1.8 Å from the center of the C82 cage. The second cumulants of these distances are relatively large and weakly depending on temperature. This points to a considerable distribution in Gd–C1 and Gd–C2 distances and confirms the relatively strong binding of the Gd ion to the C82 cage. These results will be discussed together with previous EXAFS studies and theoretical calculations of Y@C82 and La@C82
- …